Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide
- PMID: 6203836
- PMCID: PMC263282
- DOI: 10.1128/iai.45.1.113-117.1984
Mechanism of bacterial resistance to complement-mediated killing: inserted C5b-9 correlates with killing for Escherichia coli O111B4 varying in O-antigen capsule and O-polysaccharide coverage of lipid A core oligosaccharide
Abstract
The interaction of C3 and terminal complement components with three isogenic strains of Escherichia coli O111B4 varying in outer membrane and capsule composition was examined. Strains CL99 and 1-1, which possess O-antigen capsule and 74 to 77% coverage of lipid A core oligosaccharide, were sensitive to killing in pooled normal human serum (PNHS) or magnesium ethylene glycoltetraacetic acid PNHS in the presence but not the absence of antibody, although 1-1 contained 35% more lipopolysaccharide than CL99 and was slightly less sensitive to alternative pathway killing. In contrast, strain 1-2 lacks O-antigen capsule but contains 84% coverage and resists serum killing in the presence and absence of antibody in both PNHS and magnesium ethylene glycoltetraacetic acid PNHS. All three strains consumed C3 and C9 when incubated in PNHS, but consumption was most rapid with 1-2, which also bound the largest number of C3 molecules per CFU. Between 15 X 10(3) and 24 X 10(3) molecules of C9 per CFU bound to CL99 and 1-1 during incubation in 10% PNHS or 10% magnesium ethylene glycoltetraacetic acid PNHS, and binding was relatively stable. Binding and release of 3 X 10(3) to 8 X 10(3) molecules of C9 per CFU was observed for strain 1-2. The majority of C9 bound to CL99 and 1-1 in the presence of antibody distributed with the outer membrane after lysis of the organisms in a French press, whereas only 16.1 to 20.1% of C9 was deposited on these organisms in the absence of antibody, and 31.5 to 39.8% of C9 on strain 1-2 with or without antibody sedimented with the outer membrane. Between 4.6 X 10(3) and 5.5 X 10(3) molecules of C9 per CFU remained bound in a salt- and trypsin-resistant form to the outer membrane of organisms that were killed, whereas fewer than 1.4 X 10(3) molecules of C9 per CFU were bound to the outer membrane of organisms not killed by serum. These results indicate that C5b-9 that is bound to the outer membrane of E. coli O111B4 in a form resistant to salt or protease elution correlates with bacterial killing.
Similar articles
-
Studies on the mechanism of bacterial resistance to complement-mediated killing. I. Terminal complement components are deposited and released from Salmonella minnesota S218 without causing bacterial death.J Exp Med. 1982 Mar 1;155(3):797-808. doi: 10.1084/jem.155.3.797. J Exp Med. 1982. PMID: 6801179 Free PMC article.
-
Serum-resistant mutants of Escherichia coli O111 contain increased lipopolysaccharide, lack an O antigen-containing capsule, and cover more of their lipid A core with O antigen.J Bacteriol. 1984 Sep;159(3):877-82. doi: 10.1128/jb.159.3.877-882.1984. J Bacteriol. 1984. PMID: 6207166 Free PMC article.
-
Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.J Immunol. 1983 Nov;131(5):2563-9. J Immunol. 1983. PMID: 6355296
-
The killer molecule of complement.J Invest Dermatol. 1985 Jul;85(1 Suppl):47s-52s. doi: 10.1111/1523-1747.ep12275445. J Invest Dermatol. 1985. PMID: 3891882 Review.
-
Transmembrane channel-formation by five complement proteins.Biochem Soc Symp. 1985;50:235-46. Biochem Soc Symp. 1985. PMID: 2428370 Review.
Cited by
-
Determination of serum bactericidal activity against Escherichia coli by an automated photometric method.J Clin Microbiol. 1988 Oct;26(10):2069-76. doi: 10.1128/jcm.26.10.2069-2076.1988. J Clin Microbiol. 1988. PMID: 3053761 Free PMC article.
-
Serum susceptibility of Haemophilus somnus from bovine clinical cases and carriers.J Clin Microbiol. 1985 Aug;22(2):192-8. doi: 10.1128/jcm.22.2.192-198.1985. J Clin Microbiol. 1985. PMID: 4031034 Free PMC article.
-
Lipopolysaccharide O-antigens-bacterial glycans made to measure.J Biol Chem. 2020 Jul 31;295(31):10593-10609. doi: 10.1074/jbc.REV120.009402. Epub 2020 May 18. J Biol Chem. 2020. PMID: 32424042 Free PMC article. Review.
-
Lipopolysaccharide phase variation determines the complement-mediated serum susceptibility of Coxiella burnetii.Infect Immun. 1988 Jan;56(1):40-4. doi: 10.1128/iai.56.1.40-44.1988. Infect Immun. 1988. PMID: 3335408 Free PMC article.
-
Characterization of a polysaccharide capsular antigen of septicemic Escherichia coli O115:K "V165" :F165 and evaluation of its role in pathogenicity.Infect Immun. 1992 Dec;60(12):5048-56. doi: 10.1128/iai.60.12.5048-5056.1992. Infect Immun. 1992. PMID: 1452337 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Research Materials
Miscellaneous